Findings on 18FDG-PET imaging in statin-induced rhabdomyolysis

Clinical Radiology

Volumn 62, Issue 10, 2007, Pages 1012-1014

  Sheehy, N ^a   Israel, D A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ATORVASTATIN; COTRIMOXAZOLE; FLUORODEOXYGLUCOSE F 18; TACROLIMUS;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER GRADING; CANCER REGRESSION; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DRUG UPTAKE; DRUG WITHDRAWAL; FEVER; FOLLICULAR LYMPHOMA; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MYALGIA; NONHODGKIN LYMPHOMA; PANCYTOPENIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHABDOMYOLYSIS; SIDE EFFECT; SKULL; THIGH;

FLUORODEOXYGLUCOSE F18; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RHABDOMYOLYSIS;

EID: 34548246556     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2007.04.010     Document Type: Article

References (5)

1. Graham D.J., Staffa J.A., Shatin D., et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 292 (2004) 2585-2590
2. Law M., and Rudnicka A.R. Statin safety: a systematic review. Am J Cardiol 97 (2006) 52C-60C
3. Groves A.M., Cheow H.K., Win T., et al. Extensive skeletal muscle uptake of 18F-FDG: relation to immunosuppressants?. J Nucl Med Technol 32 (2004) 206-208
4. Murata Y., Kubota K., Yukihiro M., et al. Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT. Nucl Med Biol 33 (2006) 999-1004
5. Talbert R.L. Safety issues with statin therapy. J Am Pharm Assoc (Wash) 46 (2006) 479-488